Signal Transduction - Cellular Gossip Gone Wrong
- Core Concept: Faulty signaling components (receptors, G-proteins, kinases) lead to uncontrolled cellular responses, driving disease.
-
Oncogenic Overdrive:
- Ras mutations: Lock Ras in GTP-bound (active) state → constant cell division.
- HER2 amplification: ↑ Receptor Tyrosine Kinase (RTK) signaling in breast cancer.
-
Toxin-Induced Chaos:
- Cholera Toxin: Permanently activates Gs → ↑ cAMP → massive fluid secretion.
- Pertussis Toxin: Disables Gi → ↑ cAMP → impairs immune cell function.
- 📌 Cholera = Constantly on (Gs); Pertussis = Paralyzed (Gi).
⭐ Cholera toxin ADP-ribosylates the Gsα subunit, locking it in an active, GTP-bound state. This leads to constitutive adenylyl cyclase activity and massive ↑cAMP levels in intestinal epithelial cells.
GPCR Dysregulation - Mischievous G‑Proteins
-
Cholera Toxin (Vibrio cholerae)
- Target: Gαs subunit.
- Mechanism: Irreversibly activates Gs via ADP-ribosylation → constitutively active adenylyl cyclase.
- Result: Massively ↑cAMP in intestinal crypt cells → ↑$Cl^−$ secretion (CFTR) → secretory diarrhea.
-
Pertussis Toxin (Bordetella pertussis)
- Target: Gαi subunit.
- Mechanism: Irreversibly inactivates Gi via ADP-ribosylation → fails to inhibit adenylyl cyclase.
- Result: ↑cAMP → impaired chemokine signaling & ciliary dysfunction → whooping cough.
⭐ High-Yield: Both toxins act via ADP-ribosylation, permanently modifying the G-protein. This covalent modification makes their effects prolonged and severe.
Receptor Tyrosine Kinases - Kinases Causing Chaos
- Mechanism: Ligand binding (e.g., growth factors) induces receptor dimerization and autophosphorylation of tyrosine residues, creating docking sites for downstream signaling proteins.
- Key Pathways Activated:
- MAP Kinase (RAS-RAF-MEK-ERK): Promotes cell proliferation.
- PI3K-AKT-mTOR: Promotes cell survival and growth.
- Dysregulation in Cancer: Gain-of-function mutations or gene amplification lead to constitutive (ligand-independent) activation, driving uncontrolled cell growth.

- Clinical Examples:
- HER2 (ERBB2): Amplified in breast cancer. Targeted by Trastuzumab.
- EGFR: Mutated in non-small cell lung cancer. Targeted by Erlotinib, Gefitinib.
- VEGFR: Promotes angiogenesis. Targeted by Bevacizumab.
⭐ The BCR-ABL fusion protein in Chronic Myeloid Leukemia (CML) creates a constitutively active cytoplasmic tyrosine kinase, the target of the inhibitor Imatinib.
Intracellular Pathways - Intranuclear Intruders
- Lipophilic signals (steroids, thyroid hormone, Vit D) diffuse across the cell membrane.
- Bind to cytosolic or nuclear intracellular receptors, which then act as transcription factors.
- The receptor-ligand complex binds to Hormone Response Elements (HREs) on DNA, altering gene expression.
- 📌 Mnemonic: VETTT CAP (Vitamin D, Estrogen, Testosterone, T3/T4, Cortisol, Aldosterone, Progesterone).

⭐ Tamoxifen, a SERM, shows tissue-specific effects: it's an estrogen antagonist in the breast (therapeutic) but an agonist in the endometrium (↑ cancer risk) and bone (protective).
High‑Yield Points - ⚡ Biggest Takeaways
- Cholera toxin permanently activates Gsα, massively increasing cAMP and causing severe secretory diarrhea.
- Pertussis toxin disables Giα, also increasing cAMP, leading to the characteristic whooping cough.
- Mutations in the Ras proto-oncogene create a constitutively active state, promoting uncontrolled cell growth in many cancers.
- Insulin resistance in Type 2 Diabetes involves desensitization of tyrosine kinase receptors.
- Myasthenia Gravis results from autoantibodies blocking nicotinic acetylcholine receptors, causing muscle weakness.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app